Literature DB >> 18086522

Bronchiectasis in Central Australia: a young face to an old disease.

Daniel P Steinfort1, Stephen Brady, Harrison S Weisinger, Lloyd Einsiedel.   

Abstract

BACKGROUND: Bronchiectasis remains a significant cause of morbidity among specific populations world wide, including many indigenous groups. Data on prevalence in Australian adults are lacking. Indigenous children in Central Australia have the highest rates of bronchiectasis in the world. Outcomes for these individuals after they become adults are not currently available.
METHODS: We performed a retrospective case review of the presentation and likely aetiology of adult patients presenting to the Alice Springs Hospital with a primary diagnosis of bronchiectasis.
RESULTS: Sixty-one patients and 166 admissions were identified. Fifty-nine patients were indigenous (97%). Mean age was 42+/-15 years. Forty-three patients (70%) had past histories notable for recurrent respiratory tract infections. No predisposing factors could be identified in 11 patients (18%). Human T-cell lymphotropic virus type 1 (HTLV-1) serology was positive in 72% of those studied. Eight (13%) patients died during the study period.
CONCLUSION: Bronchiectasis remains a significant cause of morbidity and mortality in Central Australia, with notably different patient characteristics and disease aetiology to other published cohorts. Recurrent respiratory infection is the major cause of illness. Associated factors include indigenous ethnicity, HTLV-1 positivity and childhood in a remote region.

Entities:  

Mesh:

Year:  2007        PMID: 18086522     DOI: 10.1016/j.rmed.2007.11.007

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  15 in total

1.  Nasopharyngeal carriage and macrolide resistance in Indigenous children with bronchiectasis randomized to long-term azithromycin or placebo.

Authors:  K M Hare; K Grimwood; A B Chang; M D Chatfield; P C Valery; A J Leach; H C Smith-Vaughan; P S Morris; C A Byrnes; P J Torzillo; A C Cheng
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-12       Impact factor: 3.267

2.  Surgical treatment of non-cystic fibrosis bronchiectasis in Brazilian children.

Authors:  Cristiano Feijó Andrade; Iury Andrade Melo; Arthur Rodrigo Ronconi Holand; Éverton Franco Silva; Gilberto Bueno Fischer; José Carlos Felicetii
Journal:  Pediatr Surg Int       Date:  2013-10-09       Impact factor: 1.827

3.  Antibiotics for bronchiectasis exacerbations in children: rationale and study protocol for a randomised placebo-controlled trial.

Authors:  Anne B Chang; Keith Grimwood; Colin F Robertson; Andrew C Wilson; Peter P van Asperen; Kerry-Ann F O'Grady; Theo P Sloots; Paul J Torzillo; Emily J Bailey; Gabrielle B McCallum; Ian B Masters; Catherine A Byrnes; Mark D Chatfield; Helen M Buntain; Ian M Mackay; Peter S Morris
Journal:  Trials       Date:  2012-08-31       Impact factor: 2.279

Review 4.  Toward making inroads in reducing the disparity of lung health in Australian indigenous and new zealand māori children.

Authors:  Anne B Chang; Robyn L Marsh; John W Upham; Lucas R Hoffman; Heidi Smith-Vaughan; Deborah Holt; Maree Toombs; Catherine Byrnes; Stephanie T Yerkovich; Paul J Torzillo; Kerry-Ann F O'Grady; Keith Grimwood
Journal:  Front Pediatr       Date:  2015-02-13       Impact factor: 3.418

Review 5.  Bronchiectasis in Children: Current Concepts in Immunology and Microbiology.

Authors:  Susan J Pizzutto; Kim M Hare; John W Upham
Journal:  Front Pediatr       Date:  2017-05-29       Impact factor: 3.418

Review 6.  The Epidemiology of Chronic Suppurative Lung Disease and Bronchiectasis in Children and Adolescents.

Authors:  Gabrielle B McCallum; Michael J Binks
Journal:  Front Pediatr       Date:  2017-02-20       Impact factor: 3.418

Review 7.  A review of the role of Haemophilus influenzae in community-acquired pneumonia.

Authors:  Mary P E Slack
Journal:  Pneumonia (Nathan)       Date:  2015-12-01

Review 8.  Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis.

Authors:  Ravishankar Chandrasekaran; Micheál Mac Aogáin; James D Chalmers; Stuart J Elborn; Sanjay H Chotirmall
Journal:  BMC Pulm Med       Date:  2018-05-22       Impact factor: 3.317

9.  Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial.

Authors:  Anne B Chang; Keith Grimwood; Andrew C Wilson; Peter P van Asperen; Catherine A Byrnes; Kerry-Ann F O'Grady; Theo P Sloots; Colin F Robertson; Paul J Torzillo; Gabrielle B McCallum; Ian B Masters; Helen M Buntain; Ian M Mackay; Jacobus Ungerer; Joanne Tuppin; Peter S Morris
Journal:  Trials       Date:  2013-02-20       Impact factor: 2.279

10.  Increased Peripheral Blood Pro-Inflammatory/Cytotoxic Lymphocytes in Children with Bronchiectasis.

Authors:  G Hodge; J W Upham; A B Chang; K J Baines; S T Yerkovich; S J Pizzutto; S Hodge
Journal:  PLoS One       Date:  2015-08-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.